awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2C
Q28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2C
Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial
P2860
Q28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28194967-6AA325B0-1BE9-4825-8897-26F140FBAB2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a73a16a90df993b0ba370e2b74ec5e95dd103d4e
P2860
How should cost data in pragmatic randomised trials be analysed?